跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUGAMMADEX-TEVA SOLUTION FOR INJECTION 100MG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
SUGAMMADEX-TEVA SOLUTION FOR INJECTION 100MG/ML
Approved
THERAPEUTIC
SUGAMMADEX-TEVA SOLUTION FOR INJECTION 100MG/ML
PLIVA Croatia Ltd.
🇸🇬 Health Sciences Authority
Approval Date
Feb 26, 2024
Approval ID
a8623c0c0247d50c
Company
PLIVA Croatia Ltd.
Type
Therapeutic
Approval Details
Approval Id
a8623c0c0247d50c
Drug Name
SUGAMMADEX-TEVA SOLUTION FOR INJECTION 100MG/ML
Product Name
SUGAMMADEX-TEVA SOLUTION FOR INJECTION 100MG/ML
Approval Number
SIN16962P
Approval Date
2024-02-26
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
V03AB35
Atc Item Name
sugammadex
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path
/organization/teva-pharmaceutical-investments-singapore-pte-ltd
Active Ingredients
Sugammadex Sodium eqv. to Sugammadex
100mg/ml
Sugammadex Sodium eqv. to Sugammadex
100mg/ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 26, 2024
Approval ID
a8623c0c0247d50c
Type
Therapeutic
Back to HSA Approvals
